CSIMarket
 

Repligen Corp  (NASDAQ: RGEN)
Other Ticker:  
 

Repligen's

Competitiveness



 
 

RGEN Sales vs. its Competitors Q1 2025



Comparing the current results to its competitors, Repligen reported Revenue increase in the 1 quarter 2025 by 10.44 % year on year.
The sales growth was above Repligen's competitors' average revenue growth of 2.06 %, achieved in the same quarter.

List of RGEN Competitors

With a net margin of 3.45 % Repligen achieved higher profitability than its competitors.

More on RGEN Profitability Comparisons



Revenue Growth Comparisons




Net Income Comparison


Repligen Corp Net Income in the 1 quarter 2025 grew year on year by 76.88%, while most of its competitors have experienced a contraction in net income by -10.94 %.

<<  RGEN Stock Performance Comparisons



  

Overall company Market Share Q1 2025

Company's competitiveness improved within Overall company, with revenue growth of 10.44 % and its market share increased to approx. 0.89 %.
<<  More on RGEN Market Share.
 
*Market share is calculated based on total revenue.





Publicly Traded Peers of Repligen Corp




Thermo Fisher Scientific Inc
Share Performance



-2.33%
Over The Past 5 Days



Thermo Fisher Scientific Inc
Profile

Thermo Fisher Scientific Inc operates as a global leader in scientific research and services by delivering an extensive range of high-quality scientific instruments, reagents, consumables, and software solutions tailored to industries such as healthcare, pharmaceuticals, biotechnology, academia, and government. The company enhances its value proposition through a comprehensive suite of services, including laboratory outsourcing, scientific consulting, and data analysis, which help streamline research and development processes for its customers. By leveraging advanced technology and deep industry expertise, Thermo Fisher empowers researchers and organizations to drive innovation and accelerate scientific discovery.

More about Thermo Fisher Scientific Inc 's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 153,457.100 mill. $ 42,898.000 mill. $ 6,518.000 mill.


Danaher Corporation
Share Performance



-12.68%
This Year



Danaher Corporation
Profile

Danaher Corporation operates a diversified business model centered on developing advanced technologies and solutions across multiple sectors, particularly life sciences, diagnostics, dental, and environmental. The company emphasizes continuous innovation and operational excellence, leveraging its proprietary technologies to drive growth and improve efficiency. By strategically acquiring and integrating complementary businesses, Danaher enhances its product offerings while expanding its global market presence.

More about Danaher Corporation's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 144,642.936 mill. $ 23,820.000 mill. $ 3,765.000 mill.


Bio rad Laboratories Inc
Share Performance



+0.60%
Over The Past 5 Days



Bio rad Laboratories Inc
Profile

Bio-Rad Laboratories Inc operates as a global leader in life sciences and clinical diagnostics by focusing on the development, manufacturing, and distribution of a diverse array of products and solutions. Their business model emphasizes innovation, providing advanced tools and technologies that empower scientists and healthcare professionals to effectively analyze biological materials. By delivering high-quality solutions, Bio-Rad aims to facilitate scientific breakthroughs and enhance patient care in various healthcare settings.

More about Bio rad Laboratories Inc 's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 6,343.269 mill. $ 2,540.934 mill. $ -2,164.116 mill.


Agilent Technologies inc
Share Performance



+4.72%
30 Days



Agilent Technologies inc
Profile

Agilent Technologies Inc. operates a business model centered on delivering innovative measurement solutions across industries like life sciences, diagnostics, and chemical analysis. Their revenue primarily comes from sales of instruments, software, and consumables, supplemented by support services. The company emphasizes strong partnerships and collaborations to enhance their market presence and influence.

More about Agilent Technologies inc 's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 33,858.000 mill. $ 6,614.000 mill. $ 1,403.000 mill.


Qiagen N v
Share Performance



+18.31%
This Quarter



Qiagen N v
Profile

Qiagen N.V. is a Dutch multinational company that operates in the field of molecular diagnostics and sample preparation technologies. Their business model revolves around developing and manufacturing products and solutions for molecular testing, enabling researchers and healthcare professionals to analyze biological samples and gain insights into diseases and genetic variations. Qiagen N.V. primarily generates revenue through the sale of instruments, consumables, and related services to customers in various market segments including academia, pharmaceuticals, and diagnostics.

More about Qiagen N v 's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 10,586.418 mill. $ 1,919.350 mill. $ 83.591 mill.


Nanostring Technologies Inc
Share Performance



-73.68%
30 Days



Nanostring Technologies Inc
Profile

Nanostring Technologies Inc is a biotechnology company that develops tools and technologies for genetic analysis. Their business model revolves around the production and sale of their proprietary nCounter Analysis System, which enables researchers to simultaneously analyze hundreds of genes in a single reaction. Additionally, Nanostring provides a range of products and services for research and diagnostic purposes, catering to the needs of academic institutions, pharmaceutical companies, and clinical laboratories.

More about Nanostring Technologies Inc 's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 5.024 mill. $ 162.473 mill. $ -166.431 mill.


Bio techne Corp
Share Performance



-19.27%
This Quarter



Bio techne Corp
Profile

Bio-Techne Corp operates as a global life sciences company that provides innovative tools and solutions. They offer a diverse portfolio of products, including research reagents, diagnostic controls, and protein analysis tools, catering to the needs of academia, pharmaceutical and biotechnology companies. The company focuses on driving scientific advancements and aiding researchers in understanding biological systems by developing cutting-edge technologies and delivering high-quality products and services.

More about Bio techne Corp's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 8,029.851 mill. $ 1,218.244 mill. $ 110.507 mill.


Twist Bioscience Corporation
Share Performance



-20.83%
This Quarter



Twist Bioscience Corporation
Profile

Twist Bioscience Corporation operates as a biotechnology company that focuses on synthetic DNA manufacturing. Its business model consists of providing customers with custom DNA synthesis, gene libraries, and specialty components. This includes offering a variety of products and services tailored to meet the specific needs of researchers and biotech companies, enabling them to accelerate their development of personalized medicines, agricultural biotechnology, and more.

More about Twist Bioscience Corporation's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 1,999.434 mill. $ 347.680 mill. $ -191.148 mill.




Sources: Repligen Corp and all companies mentioned above in this report


Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2025 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com